Accelerating time to market is a priority among many medical device manufacturers, but that is easier said than done in a highly regulated industry that must meet compliance and safety requirements. Freudenberg Medical (Carpinteria, CA), a contract manufacturer serving the global medical technology industry, has developed what it calls a “novel device, design and process solution” to compress the product development timeline.
Freudenberg Medical debuted its FlexSeal Introducer Sheath, FlexSeal Hemostasis Valve and Composer Deflectable Catheter Handle platform today at the Transcatheter Cardiovascular Therapeutics Conference (TCT) in Washington, DC, the annual scientific symposium of the Cardiovascular Research Foundation. The devices are designed for companies seeking to accelerate time to market with a unique white label device, access new design options for improving next-generation catheter and delivery systems, or reducing time when building new feature sets into products, said the company.
The FlexSeal Introducer Sheath with a hydrophilic coating enables support access for large-bore catheter procedures. The FlexSeal Hemostasis Valve improves hemostasis performance when integrated into next-generation catheter or delivery systems. The Composer Deflectable Catheter Handle platform offers customers a commercialization-ready, modular and versatile design technology that can help reduce project lead times and costs while adding next-generation features into product lines that use catheters, introducer sheaths and delivery systems.
Part of the 166-year-old Freudenberg Group, Freudenberg Medical operates 11 manufacturing centers and employs more than 1,500 associates worldwide. Its services range from the fabrication of high-precision silicone and thermoplastic components and tubing to coating technology, finished devices and solutions for minimally invasive, handheld, and catheter-based devices.